Biotech

All Articles

ArsenalBio increases $325M, pivots out of past lead property

.Toolbox Biosciences is carrying on up. The cell therapy firm has added on $325 million in ammo alon...

Lilly- backed weight loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' cannabis usage medication flunks phase 2b, driving Indivior to review $100M option

.Aelis Farma's chances of safeguarding an easy, good selection on a $100 thousand alternative settle...

ProKidney standstills phase 3 trial certainly not needed for cell therapy approval

.ProKidney has ceased one of a pair of phase 3 tests for its own cell treatment for kidney health co...

Vaxcyte rises on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals referred to as "magnificent" period 1/2 data for its 31-valent ...

Recursion's brain disease test reveals insufficient evidence of efficiency

.Recursion has actually stumbled by means of an early exam of its tech-enabled strategy to medicine ...

Acepodia, Pfizer click with each other for chemistry-based cell therapy

.Call it a situation of great chemistry: Acepodia, a biotech based on Nobel Champion science, is act...

Praxis epilepsy drug lowers confiscations in period 2 trial

.Praxis Precision Medicines has actually scored another midphase succeed in epilepsy this year, alon...

Three directors resign as Dyne blog posts combined information for DMD applicant

.After getting away from a professional hold numerous years back, Dyne Therapeutics has actually sho...

Arrowhead fires off stage 3 data in rare metabolic ailment ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own give before a potential showdown with Ionis, releasi...